DGAP-News: Biotest AG: Biotest exceeds Sales and EBIT forecast in the 2020 financial year
For the Biotest Group, earnings before taxes (EBT) came in at -30.0 million, compared to -1.3 million in the same period of the previous year.
- For the Biotest Group, earnings before taxes (EBT) came in at -30.0 million, compared to -1.3 million in the same period of the previous year.
- Three activities against COVID-19 infection:
With three projects, the Biotest Group is working to contribute to the solution of the corona crisis:
1. - For financial year 2021, the Board of Management expects sales growth in the mid-single-digit percentage range.
- The ordinary and preference shares of Biotest AG are listed in the Prime Standard on the German stock exchange.